Cognition Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Mar 24 | BuyUS$9,975 | Lisa Ricciardi | Individual | 5,700 | US$1.75 |
Insider Trading Volume
Insider Buying: CGTX insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,867 | 0.0125% |
Individual Insiders | 114,651 | 0.294% |
VC/PE Firms | 6,000,000 | 15.4% |
Institutions | 6,151,774 | 15.8% |
General Public | 26,728,860 | 68.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,000,000 | US$11.6m | 9.09% | no data | |||
2,205,377 | US$4.3m | 0% | 0.02% | |||
1,448,270 | US$2.8m | -29% | 1.22% | |||
721,554 | US$1.4m | 5.05% | no data | |||
238,000 | US$459.3k | -17.9% | 0.04% | |||
219,434 | US$423.5k | 22.7% | no data | |||
205,000 | US$395.7k | 0% | 0.07% | |||
174,798 | US$337.4k | 0% | no data | |||
130,951 | US$252.7k | 721% | no data | |||
92,730 | US$179.0k | 0% | no data | |||
91,200 | US$176.0k | 37.8% | no data | |||
55,865 | US$107.8k | 128% | no data | |||
55,609 | US$107.3k | -1.11% | no data | |||
55,395 | US$106.9k | 0% | 0.01% | |||
51,471 | US$99.3k | 0% | 0.03% | |||
50,750 | US$97.9k | 0% | no data | |||
43,380 | US$83.7k | 0% | 0.05% | |||
40,874 | US$78.9k | 0% | 0.03% | |||
40,000 | US$77.2k | -20% | 0.3% | |||
37,961 | US$73.3k | 0% | no data | |||
32,962 | US$63.6k | 0% | no data | |||
30,722 | US$59.3k | 0% | no data | |||
28,550 | US$55.1k | 0% | no data | |||
24,500 | US$47.3k | 0% | no data | |||
24,019 | US$46.4k | 0% | 0.01% |